Section 340B: Drug Pricing Program

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:government_agency
gptkbp:administeredBy	gptkb:Health_Resources_and_Services_Administration
gptkbp:appliesTo	pharmaceutical manufacturers
gptkbp:codifiedIn	gptkb:42_U.S.C._§_256b
gptkbp:controversy	impact on drug pricing and hospital profits
gptkbp:dateEnacted	gptkb:Veterans_Health_Care_Act_of_1992
gptkbp:drugDiscounts	outpatient prescription drugs
gptkbp:eligibility	gptkb:Ryan_White_HIV/AIDS_Program_grantees gptkb:rural_referral_centers gptkb:sole_community_hospitals children's hospitals critical access hospitals disproportionate share hospitals federally qualified health centers
gptkbp:enactedBy	gptkb:United_States_Congress
gptkbp:excludes	inpatient drugs
https://www.w3.org/2000/01/rdf-schema#label	Section 340B: Drug Pricing Program
gptkbp:monitors	gptkb:Office_of_Pharmacy_Affairs
gptkbp:purpose	reduce drug costs for eligible health care organizations
gptkbp:requires	covered entities to prevent duplicate discounts manufacturers to provide outpatient drugs at reduced prices covered entities to prevent drug diversion
gptkbp:savingsUsedFor	expanding services to vulnerable populations
gptkbp:subject	federal audits ongoing legislative and regulatory review
gptkbp:bfsParent	gptkb:Public_Health_Service_Act
gptkbp:bfsLayer	6